These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 10449029

  • 1. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
    Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ.
    Mol Carcinog; 1999 Aug; 25(4):231-40. PubMed ID: 10449029
    [Abstract] [Full Text] [Related]

  • 2. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 3. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
    Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM.
    Mol Carcinog; 2003 Oct 01; 38(2):49-58. PubMed ID: 14502644
    [Abstract] [Full Text] [Related]

  • 6. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T, Rao CV, Seibert K, Reddy BS.
    Cancer Res; 1998 Feb 01; 58(3):409-12. PubMed ID: 9458081
    [Abstract] [Full Text] [Related]

  • 7. Is cyclooxygenase-2 important in skin carcinogenesis?
    Fischer SM.
    J Environ Pathol Toxicol Oncol; 2002 Feb 01; 21(2):183-91. PubMed ID: 12086405
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.
    Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467
    [Abstract] [Full Text] [Related]

  • 9. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
    Won YK, Ong CN, Shi X, Shen HM.
    Carcinogenesis; 2004 Aug 15; 25(8):1449-58. PubMed ID: 15033901
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA.
    Cancer Res; 2000 Sep 15; 60(18):5040-4. PubMed ID: 11016626
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N, Yamazaki R, Kawai S.
    Arthritis Rheum; 2002 Dec 15; 46(12):3159-67. PubMed ID: 12483719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.
    Pentland AP, Scott G, VanBuskirk J, Tanck C, LaRossa G, Brouxhon S.
    Cancer Res; 2004 Aug 15; 64(16):5587-91. PubMed ID: 15313895
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B.
    J Oral Pathol Med; 2004 Nov 15; 33(10):607-13. PubMed ID: 15482327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.